Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat
- 24 January 2002
- journal article
- Published by Elsevier in Brain Research
- Vol. 932 (1-2) , 45-55
- https://doi.org/10.1016/s0006-8993(02)02275-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- RS-100642-198, a novel sodium channel blocker, provides differential neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity in primary cultures of rat cerebellar neurons.Neurotoxicity Research, 2001
- Delayed Treatment With AM-36, a Novel Neuroprotective Agent, Reduces Neuronal Damage After Endothelin-1–Induced Middle Cerebral Artery Occlusion in Conscious RatsStroke, 1999
- The importance of voltage-dependent sodium channels in cerebral ischaemiaAmino Acids, 1998
- Predictive Factors of Early Seizures After Acute Cerebrovascular DiseaseStroke, 1997
- Potassium-Induced Cortical Spreading Depressions during Focal Cerebral Ischemia in Rats: Contribution to Lesion Growth Assessed by Diffusion-Weighted NMR and Biochemical ImagingJournal of Cerebral Blood Flow & Metabolism, 1996
- Different voltage dependence of transient and persistent Na+ currents is compatible with modal-gating hypothesis for sodium channelsJournal of Neurophysiology, 1994
- Postnatal development of a persistent Na+ current in pyramidal neurons from rat sensorimotor cortexJournal of Neurophysiology, 1993
- Epidemiology of strokeThe Lancet, 1992
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986